The correlation of the total antioxidant status (TAS), total oxidant status (TOS) and paraoxonase activity (PON1) with smoking

Clinical Biochemistry

Volumn 47, Issue 6, 2014, Pages 393-397

  Aslan, Raziye ^a   Kutlu, Ruhusen ^a   Civi, Selma ^a   Tasyurek, Erkan ^a  

^a University of Konya   (Turkey)

Author keywords

Paraoxonase; Smoking; Total antioxidant status; Total oxidant status

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZING AGENT; TRIACYLGLYCEROL; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING; TOBACCO DEPENDENCE; YOUNG ADULT; AGE; DEMOGRAPHY; METABOLISM; STATISTICAL MODEL;

ADULT; AGE FACTORS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BODY MASS INDEX; DEMOGRAPHY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OXIDANTS; SMOKING; YOUNG ADULT;

EID: 84897110734     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.10.002     Document Type: Article

References (25)

1. WHO report on the global tobacco epidemic [Acces. date 27.03.2012]. http://www.who.int/tobacco/mpower/mpower_report_full_2008.pdf.
2. Fronczak A., Polańska K., Usidame B., Kaleta D. Comprehensive tobacco control measures-the overview of the strategies recommended by WHO. Cent Eur J Public Health 2012, 20(1):81-86.
3. Health of Turkey Global adult tobacco survey. Turkey report [Accessed date: 27.03.2012]. http://www.who.int/tobacco/surveillance/en_tfi_gats_turkey_2009.pdf.
4. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev 2012, 70(5):257-265. [Review]. 10.1111/j.1753-4887.2012.00476.x.
5. Kopani M., Celec P., Danisovic L., Michalka P., Biro C. Oxidative stress and electron spin resonance. Clin Chim Acta 2006, 364(1-2):61-66.
6. Cavdar C., Sifil A., Camsari T. Reactive oxygen particles and antioxidant defence. J Turk Nephrol 1997, 3(4):92-95.
7. Altan N., Dincel A.S., Koca C. Diabetes mellitus and oxidative stress. Turk J Biol Biochem 2006, 31(2):51-56.
8. Mahmood I., Abdulla K.S., Othman S.H. The total antioxidant status in cigarette smoking individuals. MJBU 2007, 25(1):46-50.
9. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004, 37(4):277-285.
10. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005, 38(12):1103-1111.
11. Juretić D., Tadijanović M., Rekić B., Simeon-Rudolf V., Reiner E., Baricić M. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Croat Med J 2001, 42(2):146-150.
12. van Himbergen T.M., van Tits L.J., Roest M., Stalenhoef A.F. The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine: a review. Neth J Med 2006, 64(2):34-38.
13. Durrington P.N., Mackness B., Mackness M.I. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001, 21(4):473-480.
14. Costa L.G., Vitaloneb A., Colea T.B., Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005, 69(4):541-550.
15. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagestrom K.O. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991, 86(9):1119-1127.
16. Aksakoglu G. Research techniques and analysis methods in health 2001, 305-346. Publication Committee of Dokuz Eylul University, Izmir. 2nd ed.
17. Kaleli S., Ay M., Caglayan O., Akkaya A., Gültekin F. Determinations of serum lipid peroxide levels and lipid parameters in smokers and non-smokers. Med J SDU 1996, 3(2):17-19.
18. Sharma S.B., Dwivedi S., Prabhu K.M., Singh G., Kumar N., Lal M.K. Coronary risk variables in young asymptomatic smokers. Indian J Med Res 2005, 122(3):205-210.
19. Iribarren C., Tekawa I.S., MA Sidney S., Friedman G.D. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med 1999, 340(23):1773-1780.
20. Agarwal A., Prabakaran S.A., Said T.M. Prevention of oxidative stress injury to sperm. J Androl 2005, 26(6):654-660.
21. Marangon K., Herbeth B., Lecomte E., Paul-Dauphin A., Grolier P., Chancerelle Y., et al. Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr 1998, 67(2):231-239.
22. Köse E., Mocin Ö.Y., Celik H., Gencer M. Increased oxidative stress related to using smokeless tobacco"Maras powder". Tur Toraks Der 2011, 12(3):90-94.
23. Senti M., Tomas M., Anglada R., Elosua R., Marrugat J., Covas M.I., et al. Interrelationship of smoking, paraoxonase activity and leisure time physical activity: a population based study. Eur J Intern Med 2003, 14(3):178-184.
24. James W.R., Leviev I., Righetti A. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 2000, 101(19):2252-2257.
25. Prasad A.J.M., Kemparaju K., Frank E.A., Jaichander P., Arun A., Raju C., et al. Lack of correlation of paraoxonase (PON1) activity with smoking among the South Indians and risk of cardiovascular disease. World Appl Sci J 2010, 9(2):194-198.